WO2002060938A3 - Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof - Google Patents

Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof Download PDF

Info

Publication number
WO2002060938A3
WO2002060938A3 PCT/EP2002/000937 EP0200937W WO02060938A3 WO 2002060938 A3 WO2002060938 A3 WO 2002060938A3 EP 0200937 W EP0200937 W EP 0200937W WO 02060938 A3 WO02060938 A3 WO 02060938A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
basb212
polynucleotides
haemophilus influenza
haemophilus
Prior art date
Application number
PCT/EP2002/000937
Other languages
French (fr)
Other versions
WO2002060938A2 (en
Inventor
Joelle Thonnard
Original Assignee
Glaxosmithkline Biolog Sa
Joelle Thonnard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa, Joelle Thonnard filed Critical Glaxosmithkline Biolog Sa
Priority to EP02710052A priority Critical patent/EP1357939A2/en
Priority to AU2002228079A priority patent/AU2002228079A1/en
Priority to CA002434822A priority patent/CA2434822A1/en
Publication of WO2002060938A2 publication Critical patent/WO2002060938A2/en
Publication of WO2002060938A3 publication Critical patent/WO2002060938A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention provides BASB212 polypeptides and polynucleotides encoding BASB212 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
PCT/EP2002/000937 2001-01-31 2002-01-30 Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof WO2002060938A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP02710052A EP1357939A2 (en) 2001-01-31 2002-01-30 Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof
AU2002228079A AU2002228079A1 (en) 2001-01-31 2002-01-30 Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof
CA002434822A CA2434822A1 (en) 2001-01-31 2002-01-30 Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0102470.2 2001-01-31
GBGB0102470.2A GB0102470D0 (en) 2001-01-31 2001-01-31 Novel compounds

Publications (2)

Publication Number Publication Date
WO2002060938A2 WO2002060938A2 (en) 2002-08-08
WO2002060938A3 true WO2002060938A3 (en) 2003-04-24

Family

ID=9907871

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/000937 WO2002060938A2 (en) 2001-01-31 2002-01-30 Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof

Country Status (5)

Country Link
EP (1) EP1357939A2 (en)
AU (1) AU2002228079A1 (en)
CA (1) CA2434822A1 (en)
GB (1) GB0102470D0 (en)
WO (1) WO2002060938A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2837825T3 (en) * 2012-04-26 2021-07-01 Glaxosmithkline Biologicals Sa Antigens and antigen combinations

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997036914A1 (en) * 1996-04-01 1997-10-09 Barenkamp Stephen J High molecular weight surface proteins of non-typeable haemophilus
WO1999064067A2 (en) * 1998-06-11 1999-12-16 Smithkline Beecham Biologicals S.A. Vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391316B1 (en) * 1999-03-10 2002-05-21 University Of Saskatchewan Vaccine compositions comprising Haemophilus somnus transferrin-binding proteins and methods of use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997036914A1 (en) * 1996-04-01 1997-10-09 Barenkamp Stephen J High molecular weight surface proteins of non-typeable haemophilus
WO1999064067A2 (en) * 1998-06-11 1999-12-16 Smithkline Beecham Biologicals S.A. Vaccine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 1 November 1995 (1995-11-01), FLEISCHMANN R.D. ET AL: "Outer membrane antigenic lipoprotein B precursor", XP002214374, Database accession no. P44833 *
DATABASE EMBL [online] 9 August 1995 (1995-08-09), FLEISCHMANN R.D. ET AL.: "Haemophilus influenzae Rd section 68 of 163 of the complete genome.", XP002214375, Database accession no. u32753 *

Also Published As

Publication number Publication date
WO2002060938A2 (en) 2002-08-08
AU2002228079A1 (en) 2002-08-12
CA2434822A1 (en) 2002-08-08
EP1357939A2 (en) 2003-11-05
GB0102470D0 (en) 2001-03-14

Similar Documents

Publication Publication Date Title
WO1999058562A3 (en) Novel compounds
WO1999055873A3 (en) Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
AU3164600A (en) Novel compounds
WO2000043519A3 (en) Neisseria meningitidis polypeptides
GB9809683D0 (en) Novel compounds
WO2002030971A3 (en) Basb205 polypeptides and polynucleotides coding therefor
WO2002034768A3 (en) Polypeptides and polynucleodides from haemophilus influenzae and their use
AU4504999A (en) Novel compounds
WO2002030960A3 (en) Polypeptide from haemophilus influenza
WO2002088361A3 (en) Haemophilus influenzae antigens
WO2002060938A3 (en) Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof
AU4567300A (en) Novel compounds
WO1999064602A3 (en) Moraxella catarrhalis polynucleotides and polypeptides
WO2003010195A3 (en) Novel compounds
WO2002034772A3 (en) Novel compounds
WO2003055905A3 (en) Proteins of non typable haemophilus influenzae
GB9918208D0 (en) Novel compounds
WO2002030967A3 (en) Novel compounds
WO2002046215A3 (en) Basb221 polypeptides and polynucleotides encoding basb221 polypeptides
WO2002066503A3 (en) H. influenzae antigen basb213
WO2002024729A3 (en) Haemophilus influenzae basb202 polypeptide, production, vaccine and diagnostic use
WO2002034778A3 (en) Baseb209 polypeptides and polynucleotides from haemophilus influenzae
AU6832300A (en) Novel compounds
GB9918302D0 (en) Novel compounds
WO2002079237A3 (en) Non-typeable haemophilus influenzae immunogenic polypeptides and use thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2434822

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002710052

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002710052

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP